Virus-like particles (VLPs) are non‐infectious, self‐assembling protein structures that mimic the architecture of native viruses without harbouring genetic material. Their precise nanoscale geometry ...
Breakthrough directed evolution system boosts virus-like particles for safer, more efficient gene editing, offering a powerful tool for next-generation therapeutic innovations. Study: Directed ...
The CDC's Advisory Committee on Immunization Practices (ACIP) unanimously recommended that U.S. travelers ages 12 years and older receive the virus-like particle chikungunya vaccine (Vimkunya) when ...
Vaccine Company's proprietary In Vivo Nanoparticle (IVN) technologies are designed to enable the antigen display known to elicit durable immune responses associated with virus-lik ...
A more effective vaccine technology may be on the horizon. In a new study in mice, researchers from the University of Copenhagen demonstrate that a simple addition to mRNA vaccines can significantly ...
Nipah virus (NiV), a zoonotic paramyxovirus with significant human health implications, has garnered considerable attention due to its high fatality rates and potential for human-to-human transmission ...
Collectively, the deals reposition vaccines as long-horizon disease-modifying infrastructure, leveraging epidemiologic and mechanistic links between infections (eg, VZV, EBV) and neurodegeneration, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results